AstraZeneca's new AI tool could predict more than a thousand diseases before diagnosis
A study published today in Nature Genetics examines AstraZeneca's new tool, MILTON, which uses artificial intelligence to detect biomarkers and predict diseases before they are diagnosed. According to this analysis, the tool could potentially predict over a thousand diseases and may even be more effective than the currently available polygenic risk scores.